Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06626464
PHASE1

A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.

Official title: A Phase 1 Clinical Study to Evaluate the Absorption, Metabolism and Excretion of [14C]MK-8189 in Healthy Adults

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2022-05-13

Completion Date

2022-07-08

Last Updated

2026-04-13

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

[14C]Elpipodect

Oral administration

Locations (1)

Labcorp Clinical Research Unit Inc. (Site 0001)

Madison, Wisconsin, United States